Articles by Sharon DeBacco - Pharmaceutical Executive

ADVERTISEMENT

Articles by Sharon DeBacco

Sharon DeBacco

Consumer marketing communications

Case Study: Brand Equity in Acid Reflux
April 1, 2002

A targeted effort that supported the 2001 launch of AstraZeneca's gastroesophageal reflux disease (GERD) treatment Nexium (esomeprazole) struck a fine balance in building brand equity while encouraging appropriate use of the new medication. Nexium succeeded Prilosec (omeprazole), the long-time market-leading proton pump inhibitor (PPI) that achieved US sales of $3.7 billion in 2001. Research showed that patients could benefit from another treatment alternative. Nexium was launched to the medical community on the strength of data comparing it with Prilosec.

ADVERTISEMENT

Click here